Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset.

Polo Y La Borda J, Szczypiorska M, Bartolomé N, Campos J, Flores-Robles BJ, Sanz J, Fernández-Espartero C, Clavaguera T, Andrus RF, Artieda M, Tejedor D, Martínez A, Mulero J, Isasi CM, Andréu JL, Sánchez A.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):215-221. Epub 2018 Sep 17.

2.

Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.

Rodrigues R, Artieda M, Tejedor D, Martínez A, Konstantinova P, Petry H, Meyer C, Corzo D, Sundgreen C, Klor HU, Gouni-Berthold I, Westphal S, Steinhagen-Thiessen E, Julius U, Winkler K, Stroes E, Vogt A, Hardt P, Prophet H, Otte B, Nordestgaard BG, Deeb SS, Brunzell JD.

J Clin Lipidol. 2016 Mar-Apr;10(2):394-409. doi: 10.1016/j.jacl.2015.12.015. Epub 2015 Dec 24.

PMID:
27055971
3.

A genetic predictive model for canine hip dysplasia: integration of Genome Wide Association Study (GWAS) and candidate gene approaches.

Bartolomé N, Segarra S, Artieda M, Francino O, Sánchez E, Szczypiorska M, Casellas J, Tejedor D, Cerdeira J, Martínez A, Velasco A, Sánchez A.

PLoS One. 2015 Apr 13;10(4):e0122558. doi: 10.1371/journal.pone.0122558. eCollection 2015.

4.

Improved prediction of knee osteoarthritis progression by genetic polymorphisms: the Arthrotest Study.

Blanco FJ, Möller I, Romera M, Rozadilla A, Sánchez-Lázaro JA, Rodríguez A, Gálvez J, Forés J, Monfort J, Ojeda S, Moragues C, Caracuel MÁ, Clavaguera T, Valdés C, Soler JM, Orellana C, Belmonte MÁ, Martín F, Giménez S, Úcar E, Pous J, Bartolomé N, Artieda M, Szczypiorska M, Tejedor D, Martínez A, Montell E, Martínez H, Herrero M, Vergés J; Arthrotest Study Group.

Rheumatology (Oxford). 2015 Jul;54(7):1236-43. doi: 10.1093/rheumatology/keu478. Epub 2015 Jan 7.

PMID:
25573839
5.

Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis.

Schiotis R, Sánchez A, Escudero A, Bartolomé N, Szczypiorska M, Font P, Martínez A, Tejedor D, Artieda M, Mulero J, Buzoianu A, Collantes-Estévez E.

Rheumatol Int. 2014 Jun;34(6):793-801. doi: 10.1007/s00296-013-2913-y. Epub 2013 Dec 15.

PMID:
24337767
6.

Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.

Cleynen I, Vazeille E, Artieda M, Verspaget HW, Szczypiorska M, Bringer MA, Lakatos PL, Seibold F, Parnell K, Weersma RK, Mahachie John JM, Morgan-Walsh R, Staelens D, Arijs I, De Hertogh G, Müller S, Tordai A, Hommes DW, Ahmad T, Wijmenga C, Pender S, Rutgeerts P, Van Steen K, Lottaz D, Vermeire S, Darfeuille-Michaud A.

Gut. 2014 Aug;63(8):1265-74. doi: 10.1136/gutjnl-2012-303205. Epub 2013 Oct 3.

PMID:
24092863
7.

Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.

Cleynen I, González JR, Figueroa C, Franke A, McGovern D, Bortlík M, Crusius BJ, Vecchi M, Artieda M, Szczypiorska M, Bethge J, Arteta D, Ayala E, Danese S, van Hogezand RA, Panés J, Peña SA, Lukas M, Jewell DP, Schreiber S, Vermeire S, Sans M.

Gut. 2013 Nov;62(11):1556-65. doi: 10.1136/gutjnl-2011-300777. Epub 2012 Dec 21.

PMID:
23263249
8.

Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.

Schiotis R, Bartolomé N, Sánchez A, Szczypiorska M, Sanz J, Cuende E, Collantes Estevez E, Martínez A, Tejedor D, Artieda M, Buzoianu A, Mulero J.

PLoS One. 2012;7(9):e43428. doi: 10.1371/journal.pone.0043428. Epub 2012 Sep 12.

9.

Genetic predisposition to early recurrence in clinically localized prostate cancer.

Borque Á, del Amo J, Esteban LM, Ars E, Hernández C, Planas J, Arruza A, Llarena R, Palou J, Herranz F, Raventós CX, Tejedor D, Artieda M, Simon L, Martínez A, Carceller E, Suárez M, Allué M, Sanz G, Morote J.

BJU Int. 2013 Apr;111(4):549-58. doi: 10.1111/j.1464-410X.2012.11333.x. Epub 2012 Jul 3.

10.

Genetic polymorphisms inside and outside the MHC improve prediction of AS radiographic severity in addition to clinical variables.

Bartolomé N, Szczypiorska M, Sánchez A, Sanz J, Juanola-Roura X, Gratacós J, Zarco-Montejo P, Collantes E, Martínez A, Tejedor D, Artieda M, Mulero J.

Rheumatology (Oxford). 2012 Aug;51(8):1471-8. doi: 10.1093/rheumatology/kes056. Epub 2012 Apr 11.

PMID:
22495925
11.

The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.

Cáliz R, del Amo J, Balsa A, Blanco F, Silva L, Sanmarti R, Martínez FG, Collado MD, Ramirez Mdel C, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Andreu JL, Graell E, Simon L, Martínez A, Mulero J.

Scand J Rheumatol. 2012 Feb;41(1):10-4. doi: 10.3109/03009742.2011.617312. Epub 2011 Nov 1.

PMID:
22044028
12.

ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population.

Szczypiorska M, Sánchez A, Bartolomé N, Arteta D, Sanz J, Brito E, Fernández P, Collantes E, Martínez A, Tejedor D, Artieda M, Mulero J.

Rheumatology (Oxford). 2011 Nov;50(11):1969-75. doi: 10.1093/rheumatology/ker229. Epub 2011 Aug 24.

PMID:
21865284
13.

Association of the intergenic single-nucleotide polymorphism rs10865331 (2p15) with ankylosing spondylitis in a Spanish population.

Sánchez A, Szczypiorska M, Juanola X, Bartolomé N, Gratacós J, Zarco P, Collantes E, Artieda M, Martínez A, Tejedor D, Mulero J.

J Rheumatol. 2010 Nov;37(11):2345-7. doi: 10.3899/jrheum.100211. Epub 2010 Sep 1. Erratum in: J Rheumatol. 2010 Nov;37(11):2444.

PMID:
20810504
14.

Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.

Morote J, Del Amo J, Borque A, Ars E, Hernández C, Herranz F, Arruza A, Llarena R, Planas J, Viso MJ, Palou J, Raventós CX, Tejedor D, Artieda M, Simón L, Martínez A, Rioja LA.

J Urol. 2010 Aug;184(2):506-11. doi: 10.1016/j.juro.2010.03.144. Epub 2010 Jun 17.

PMID:
20620409
15.

Can we predict top-level sports performance in power vs endurance events? A genetic approach.

Buxens A, Ruiz JR, Arteta D, Artieda M, Santiago C, González-Freire M, Martínez A, Tejedor D, Lao JI, Gómez-Gallego F, Lucia A.

Scand J Med Sci Sports. 2011 Aug;21(4):570-9. doi: 10.1111/j.1600-0838.2009.01079.x. Epub 2010 Mar 10.

PMID:
20459474
16.

Can we identify a power-oriented polygenic profile?

Ruiz JR, Arteta D, Buxens A, Artieda M, Gómez-Gallego F, Santiago C, Yvert T, Morán M, Lucia A.

J Appl Physiol (1985). 2010 Mar;108(3):561-6. doi: 10.1152/japplphysiol.01242.2009. Epub 2009 Dec 31.

17.

Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms.

Balsa A, Del Amo J, Blanco F, Caliz R, Silva L, Sanmarti R, Martínez FG, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Collado MD, Andreu JL, Graell E, Simón L, Martínez A, Mulero J.

Rheumatology (Oxford). 2010 Mar;49(3):458-66. doi: 10.1093/rheumatology/kep380. Epub 2009 Dec 23.

PMID:
20032229
18.

Are elite endurance athletes genetically predisposed to lower disease risk?

Gómez-Gallego F, Ruiz JR, Buxens A, Altmäe S, Artieda M, Santiago C, González-Freire M, Verde Z, Arteta D, Martínez A, Tejedor D, Lao JI, Arenas J, Lucia A.

Physiol Genomics. 2010 Mar 3;41(1):82-90. doi: 10.1152/physiolgenomics.00183.2009. Epub 2009 Dec 22.

PMID:
20028936
19.

The -174 G/C polymorphism of the IL6 gene is associated with elite power performance.

Ruiz JR, Buxens A, Artieda M, Arteta D, Santiago C, Rodríguez-Romo G, Lao JI, Gómez-Gallego F, Lucia A.

J Sci Med Sport. 2010 Sep;13(5):549-53. doi: 10.1016/j.jsams.2009.09.005. Epub 2009 Oct 22.

PMID:
19853505
20.

The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports.

Gómez-Gallego F, Ruiz JR, Buxens A, Artieda M, Arteta D, Santiago C, Rodríguez-Romo G, Lao JI, Lucia A.

Eur J Appl Physiol. 2009 Nov;107(5):565-9. doi: 10.1007/s00421-009-1166-7. Epub 2009 Aug 22.

PMID:
19701646
21.

Trp64Arg polymorphism in ADRB3 gene is associated with elite endurance performance.

Santiago C, Ruiz JR, Buxens A, Artieda M, Arteta D, González-Freire M, Rodríguez-Romo G, Altmäe S, Lao JI, Gómez-Gallego F, Lucia A.

Br J Sports Med. 2011 Feb;45(2):147-9. doi: 10.1136/bjsm.2009.061366. Epub 2009 Jun 23.

PMID:
19553224
22.

Association and linkage disequilibrium analyses of APOE polymorphisms in atherosclerosis.

Artieda M, Gañán A, Cenarro A, García-Otín AL, Jericó I, Civeira F, Pocoví M.

Dis Markers. 2008;24(2):65-72.

23.

Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein.

Artieda M, Cenarro A, Gañán A, Lukic A, Moreno E, Puzo J, Pocoví M, Civeira F.

Cardiology. 2007;108(4):297-306. Epub 2007 Feb 9.

PMID:
17290100
24.

Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemia.

Tejedor D, Castillo S, Mozas P, Jiménez E, López M, Tejedor MT, Artieda M, Alonso R, Mata P, Simón L, Martínez A, Pocoví M.

Clin Chem. 2006 Oct;52(10):1971-2. No abstract available.

25.

Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.

Cenarro A, Artieda M, Gonzalvo C, Meriño-Ibarra E, Arístegui R, Gañán A, Díaz C, Sol JM, Pocoví M, Civeira F; ATOMIX Study Group.

Am Heart J. 2005 Dec;150(6):1154-62.

PMID:
16338252
26.

Ultrasonography for the evaluation of visceral fat and the metabolic syndrome.

Meriño-Ibarra E, Artieda M, Cenarro A, Goicoechea J, Calvo L, Guallar A, Civeira F.

Metabolism. 2005 Sep;54(9):1230-5.

PMID:
16125535
27.

Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL.

Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M, Civeira F.

FEBS Lett. 2005 Aug 15;579(20):4503-12.

28.

Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia.

Tejedor D, Castillo S, Mozas P, Jiménez E, López M, Tejedor MT, Artieda M, Alonso R, Mata P, Simón L, Martínez A, Pocoví M; Spanish FH Group.

Clin Chem. 2005 Jul;51(7):1137-44. Epub 2005 May 12.

29.

Serum chitotriosidase activity is increased in subjects with atherosclerosis disease.

Artieda M, Cenarro A, Gañán A, Jericó I, Gonzalvo C, Casado JM, Vitoria I, Puzo J, Pocoví M, Civeira F.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1645-52. Epub 2003 Jul 31.

PMID:
12893688
30.

[Differences in clinical presentation between subjects with a phenotype of familial hypercholesterolemia determined by defects in the LDL-receptor and defects in Apo B-100].

García-Alvarez I, Castillo S, Mozas P, Tejedor D, Reyes G, Artieda M, Cenarro A, Alonso R, Mata P, Pocovi M, Civeira F; Grupo de Estudio de la Hipercolesterolemia Familiar.

Rev Esp Cardiol. 2003 Aug;56(8):769-74. Spanish.

31.

A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.

Cenarro A, Artieda M, Castillo S, Mozas P, Reyes G, Tejedor D, Alonso R, Mata P, Pocoví M, Civeira F; Spanish FH group.

J Med Genet. 2003 Mar;40(3):163-8.

Supplemental Content

Loading ...
Support Center